Table 3.
Models | AUC(95%CI) | P -value | |
---|---|---|---|
Single-model | PGI | 0.549(0.506–0.595) | |
PGII | 0.641(0.596–0.682) | ||
PGI/II | 0.735(0.696–0.773) | ||
HpAb | 0.736(0.700–0.775) | ||
OPN | 0.715(0.675–0.752) | ||
Dual-model | PGI/II-OPN | 0.787(0.752–0.822) | <0.001a, <0.001b |
PGI/II-HpAb | 0.786(0.751–0.820) | <0.001a, <0.001c | |
OPN- HpAb | 0.801(0.768–0.834) | <0.001b, <0.001c | |
Tri-model | PGI/II-HpAb-OPN | 0.826(0.795–0.858) | <0.001d, <0.001e,0.006f |
Lauren classification | |||
intestinal | 0.827(0.796–0.858) | 0.219g | |
diffuse | 0.826(0.795–0.858) | ||
Tumor stage | |||
early | 0.821(0.789–0.852) | 0.469h | |
late | 0.816(0.784–0.848) |
aCompared with the AUC of PGI/II.
bCompared with the AUC of OPN.
cCompared with the AUC of HpAb.
dCompared with the AUC of PGI/II-OPN.
eCompared with the AUC of PGI/II-HpAb.
fCompared with the AUC of OPN- HpAb.
gCompared with the AUC between Lauren classification.
hCompared with the AUC between stage.